| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ACURA PHARMACEUTICALS, INC | VP, Pharmaceutical Sciences - APT | Common Stock | 486,001 | 20 Nov 2023 | Direct | ||
| ACURA PHARMACEUTICALS, INC | VP, Pharmaceutical Sciences - APT | Restricted Stock Unit (2017 Plan) | 40,000 | 03 Jan 2023 | Direct | ||
| ACURA PHARMACEUTICALS, INC | VP, Pharmaceutical Sciences - APT | Restricted Stock Unit (2021 Plan) | 0 | 20 Nov 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000110465923119811-brzeczko-albert-w-2023-11-20 | ACURA PHARMACEUTICALS, INC | 20 Nov 2023 | 2 | $0 | 4 | VP, Pharmaceutical Sciences - APT | 20 Nov 2023, 12:07 |
| /report/000110465923001410-brzeczko-albert-w-2023-01-03 | ACURA PHARMACEUTICALS, INC | 03 Jan 2023 | 2 | $0 | 4 | VP, Pharmaceutical Sciences - APT | 05 Jan 2023, 15:08 |
| /report/000110465922086715-brzeczko-albert-w-2022-08-03 | ACURA PHARMACEUTICALS, INC | 03 Aug 2022 | 3 | $0 | 4 | VP, Pharma Sciences - APT | 05 Aug 2022, 16:17 |
| /report/000110465922035551-brzeczko-albert-w-2022-03-16 | ACURA PHARMACEUTICALS, INC | 16 Mar 2022 | 1 | $0 | 4 | VP, Pharma Sciences - APT | 18 Mar 2022, 16:05 |